{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:48:52Z","timestamp":1791614932017,"version":"4.3.4"},"reference-count":25,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.3724\/abbs.2026168","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:01:18Z","timestamp":1789462878000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Sestrin2 mitigates obesity-associated HFpEF via adaptive IRE1α-XBP1 signaling and redox regulation"],"prefix":"10.3724","author":[{"given":"Kexin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxia","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoji","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.115.306883","volume":"118","author":"Ortega FB","year":"2016","unstructured":"Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res, 2016, 118: 1752-1770.","journal-title":"Circ Res"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1093\/eurjpc\/zwac187","volume":"29","author":"Lopez-Jimenez F","year":"2022","unstructured":"Lopez-Jimenez F, Almahmeed W, Bays H, Cuevas A, Di Angelantonio E, le Roux CW, Sattar N. Obesity and cardiovascular disease: mechanistic insights and management strategies. a joint position paper by the world heart federation and world obesity federation. Eur J Prev Cardiol, 2022, 29: 2218-2237.","journal-title":"Eur J Prev Cardiol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1515\/jtim-2025-0017","volume":"13","author":"Chen A","year":"2025","unstructured":"Chen A, Zhang Y, Zhang J. Comparison of predicting value of triglyceride-glucose indices family in cardiovascular disease risk over time: insights from a 9-year nationwide prospective cohort study. J Transl Internal Med, 2025, 13: 180-182.","journal-title":"J Transl Internal Med"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pcad.2023.05.003","volume":"78","author":"Aryee EK","year":"2023","unstructured":"Aryee EK, Ozkan B, Ndumele CE. Heart failure and obesity: the latest pandemic. Prog Cardiovasc Dis, 2023, 78: 43-48.","journal-title":"Prog Cardiovasc Dis"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","volume":"118","author":"Borlaug BA","year":"2023","unstructured":"Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res, 2023, 118: 3434-3450.","journal-title":"Cardiovasc Res"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41401-023-01152-0","volume":"45","author":"Gao S","year":"2024","unstructured":"Gao S, Liu XP, Li TT, Chen L, Feng YP, Wang YK, Yin YJ. Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery. Acta Pharmacol Sin, 2024, 45: 23-35.","journal-title":"Acta Pharmacol Sin"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41569-024-01067-1","volume":"22","author":"Fayyaz AU","year":"2025","unstructured":"Fayyaz AU, Eltony M, Prokop LJ, Koepp KE, Borlaug BA, Dasari S, Bois MC. Pathophysiological insights into HFpEF from studies of human cardiac tissue. Nat Rev Cardiol, 2025, 22: 90-104.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"e006414","DOI":"10.1161\/CIRCHEARTFAILURE.119.006414","volume":"13","author":"Sabbah MS","year":"2020","unstructured":"Sabbah MS, Fayyaz AU, de Denus S, Felker GM, Borlaug BA, Dasari S, Carter RE. Obese-inflammatory phenotypes in heart failure with preserved ejection fraction. Circ Heart Fail, 2020, 13:","journal-title":"Circ Heart Fail"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3724\/abbs.2026078","volume":"58","author":"Zhang S","year":"2026","unstructured":"Zhang S, Cui Y, Chen J, Zhou S, Zhang Y, Li K, Hou Y. SGLT2 inhibitor dapagliflozin treats heart failure with preserved ejection fraction via the SIRT1\/PGC-1 pathway. Acta Biochim Biophys Sin, 2026, 58: 1624-1636.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3724\/abbs.2024238","volume":"57","author":"Chen S","year":"2024","unstructured":"Chen S, Lu Z. Macrophage NLRP3-dependent IL-1\u03b2 production contributes to aortic fibrosis in heart failure with preserved ejection fraction. Acta Biochim Biophys Sin, 2024, 57: 1175-1183.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"Schiattarella GG","year":"2019","unstructured":"Schiattarella GG, Altamirano F, Tong D, French KM, Villalobos E, Kim SY, Luo X. Nitrosative stress drives heart failure with preserved ejection fraction. Nature, 2019, 568: 351-356.","journal-title":"Nature"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1161\/CIRCULATIONAHA.124.072194","volume":"151","author":"Fonseka O","year":"2025","unstructured":"Fonseka O, Raja R, Ross C, Gare SR, Zhang J, Hille SS, King K. XBP1s-EDEM2 prevents the onset and development of HFpEF by ameliorating cardiac lipotoxicity. Circulation, 2025, 151: 1583-1605.","journal-title":"Circulation"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41569-021-00511-w","volume":"18","author":"Ren J","year":"2021","unstructured":"Ren J, Bi Y, Sowers JR, Hetz C, Zhang Y. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases. Nat Rev Cardiol, 2021, 18: 499-521.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.5603\/cj.97962","volume":"31","author":"Momot K","year":"2024","unstructured":"Momot K, Wojciechowska M, Krauz K, Czarzasta K, Puchalska L, Zar\u0119bi\u0144ski M, Cudnoch-J\u0119drzejewska A. Endoplasmic reticulum stress and expression of nitric oxide synthases in heart failure with preserved and with reduced ejection fraction\u2014pilot study. Cardiol J, 2024, 31: 885-894.","journal-title":"Cardiol J"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12986-024-00834-8","volume":"21","author":"Zhang L","year":"2024","unstructured":"Zhang L, Kan C, Shi J, Qiu H, Zhang J, Ding W, Xu L. Sestrin2 knockout exacerbates high-fat diet induced metabolic disorders and complications in female mice. Nutr Metab (Lond), 2024, 21:","journal-title":"Nutr Metab (Lond)"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"102762","DOI":"10.1016\/j.arr.2025.102762","volume":"109","author":"Machado IF","year":"2025","unstructured":"Machado IF, Palmeira CM, Rolo AP. Sestrin2 is a central regulator of mitochondrial stress responses in disease and aging. Ageing Res Rev, 2025, 109:","journal-title":"Ageing Res Rev"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2337\/db19-0991","volume":"69","author":"Sun X","year":"2020","unstructured":"Sun X, Han F, Lu Q, Li X, Ren D, Zhang J, Han Y. Empagliflozin ameliorates obesity-related cardiac dysfunction by regulating sestrin2-mediated AMPK-mTOR signaling and redox homeostasis in high-fat diet-induced obese mice. Diabetes, 2020, 69: 1292-1305.","journal-title":"Diabetes"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12944-024-02293-9","volume":"23","author":"Luo Y","year":"2024","unstructured":"Luo Y, Ye T, Tian H, Song H, Kan C, Han F, Hou N. Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formation. Lipids Health Dis, 2024, 23:","journal-title":"Lipids Health Dis"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"e76941","DOI":"10.1371\/journal.pone.0076941","volume":"8","author":"Mori T","year":"2013","unstructured":"Mori T, Hayashi T, Hayashi E, Su TP, Okamoto S. Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-er-nucleus signaling for cellular survival. PLoS One, 2013, 8:","journal-title":"PLoS One"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12858-015-0040-y","volume":"16","author":"Natsvlishvili N","year":"2015","unstructured":"Natsvlishvili N, Goguadze N, Zhuravliova E, Mikeladze D. Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria. BMC Biochem, 2015, 16:","journal-title":"BMC Biochem"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"e70072","DOI":"10.14814\/phy2.70072","volume":"12","author":"Werbner B","year":"2024","unstructured":"Werbner B, Stephens SL, Stuart D, Hotchkiss TM, Chapman J, Funai K, Ramkumar N. Hypertension and obesity independently drive hypertrophy and alter mitochondrial metabolism in a mouse model of heart failure with preserved ejection fraction. Physiol Rep, 2024, 12:","journal-title":"Physiol Rep"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12944-025-02703-6","volume":"24","author":"Li B","year":"2025","unstructured":"Li B, Rao J, Hu W, Yang Y, Zhou Q, Wu Y, Liu F. Adropin as a therapeutic candidate for HFpEF: evidence of oxidative stress mitigation via Nrf2\/HO-1 signaling. Lipids Health Dis, 2025, 24:","journal-title":"Lipids Health Dis"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41467-021-21931-9","volume":"12","author":"Schiattarella GG","year":"2021","unstructured":"Schiattarella GG, Altamirano F, Kim SY, Tong D, Ferdous A, Piristine H, Dasgupta S. Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction. Nat Commun, 2021, 12:","journal-title":"Nat Commun"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"eaau5266","DOI":"10.1126\/scitranslmed.aau5266","volume":"11","author":"Rosen DA","year":"2019","unstructured":"Rosen DA, Seki SM, Fern\u00e1ndez-Casta\u00f1eda A, Beiter RM, Eccles JD, Woodfolk JA, Gaultier A. Modulation of the Sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis. Sci Transl Med, 2019, 11:","journal-title":"Sci Transl Med"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cca.2019.04.084","volume":"495","author":"Wang H","year":"2019","unstructured":"Wang H, Li N, Shao X, Li J, Guo L, Yu X, Sun Y. Increased plasma sestrin2 concentrations in patients with chronic heart failure and predicted the occurrence of major adverse cardiac events: a 36-month follow-up cohort study. Clinica Chim Acta, 2019, 495: 338-344.","journal-title":"Clinica Chim Acta"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/4DFD5B48DB4E472EA41022130BC087C2","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026168","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/4DFD5B48DB4E472EA41022130BC087C2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:06:33Z","timestamp":1791612393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026168","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}